Clinical Study Results
Where can I learn more about this study?
You can find more information about this study on the websites listed below. If a full
report of the study results is available, it also can be found here.
• www.clinicaltrials.gov. Once you are on the website, type “NCT02454933” into
the search box and click “Search”.
• www.AstraZenecaClinicalTrials.com. Once you are on the website, type
“D5165C00001” into the search box and click “Find a Study”.
Full Trial Title: A Phase III, Multi-Centre, Open Label, Randomized Study to
Assess the Efficacy and Safety of AZD9291 in Combination with MEDI4736 versus
AZD9291 Monotherapy in Patients with Locally Advanced or Metastatic Epidermal
Growth Factor Receptor T790M mutation-positive Non-Small Cell Lung Cancer who
have received Prior Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor
Therapy (CAURAL)
AstraZeneca Protocol Number: D5165C00001
AstraZeneca sponsored this study and has its headquarters at
1800 Concord Pike in Wilmington, Delaware.
The phone number for the AstraZeneca Information Center is +1 877 240 9479.
Thank you!
Clinical study participants belong to a large community of people who take part in
clinical research around the world. They help researchers answer important health
questions and find medical treatments for participants.
The Center for Information & Study on Clinical Research
Participation (CISCRP) is a non-profit organization focused
on educating and informing the public about clinical research
participation. CISCRP is not involved in recruiting participants for
clinical studies, nor is it involved in conducting clinical studies.
CISCRP
One Liberty Square, Suite 510 • Boston, MA 02109
1-877-MED-HERO • www.ciscrp.org
Version: V1.1 10/2018 8